It has been reported that even if the primary site of breast cancer are positive for estrogen receptor (ER) and progesterone receptor (PR) expression, gastric metastases can still be negative for estrogen receptor (ER) and progesterone receptor (PR) status [8]; therefore, the diagnosis of breast cancer metastases by hormone receptor expression status is not yet reliable. This evidence concerns the gene ESR1 and breast carcinoma.